ENTITY
Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD US)

27
Analysis
Health CareUnited States
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
more
Company Event28 Feb 2025 05:00 • Upcoming
Add To Calendar
Company Event07 Nov 2024 05:30 • Latest
Company Event23 Aug 2024 20:00 • Upcoming
Add To Calendar
Company Event07 Aug 2024 04:30
Company Event09 May 2024 04:30
x